Phase IV Study of Safety and Efficacy of Everolimus (Afinitor ®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Condition: Renal Angiomyolipoma Intervention: Drug: everolimus Sponsor: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 16, 2018 Category: Research Source Type: clinical trials
